Research Focus

Former Employee. MEDICINE; Office Coordinator, Hospital Operations

Recent additions – View all

1. A phase 3, randomized, double-blind, placebo-controlled study of transarterial chemoembolization combined with durvalumab or durvalumab plus bevacizumab therapy in patients with locoregional hepatocellular carcinoma: EMERALD-1

   Meeting Abstract

   Sangro, B.; Kudo, M.; Qin, S.; Ren, Z.; Chan, S.; Joseph, E.; Arai, Y.; Mann, H.; Morgan, S.; Cohen, G.; more...
   Annals of Oncology (2020)

   Fulltext@MSK | Save